{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:40:17Z","timestamp":1790523617018,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T00:00:00Z","timestamp":1581292800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T00:00:00Z","timestamp":1581292800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018836","name":"Sheffield Teaching Hospitals NHS Foundation Trust","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100018836","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008509","name":"Open University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008509","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Idiopathic intracranial hypertension (IIH) is a neurological disorder characterised by raised cerebrospinal fluid (CSF) pressure in the absence of any intracranial pathology. IIH mainly affects women with obesity between the ages of 15 and 45. Two possible mechanisms that could explain the increased CSF pressure in IIH are excessive CSF production by the choroid plexus (CP) epithelium or impaired CSF drainage from the brain. However, the molecular mechanisms controlling these mechanisms in IIH remain to be determined.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In vivo ventriculo-cisternal perfusion (VCP) and variable rate infusion (VRI) techniques were used to assess changes in rates of CSF secretion and resistance to CSF drainage in female and male Wistar rats fed either a control (C) or high-fat (HF) diet (under anaesthesia with 20\u00a0\u03bcl\/100\u00a0g medetomidine, 50\u00a0\u03bcl\/100\u00a0g ketamine i.p). In addition, CSF secretion and drainage were assessed in female rats following treatment with inflammatory mediators known to be elevated in the CSF of IIH patients: C\u2013C motif chemokine ligand 2 (CCL2), interleukin (IL)-17 (IL-17), IL-6, IL-1\u03b2, tumour necrosis factor-\u03b1 (TNF-\u03b1), as well as glucocorticoid hydrocortisone (HC).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Female rats fed the HF diet had greater CSF secretion compared to those on control diet (3.18\u2009\u00b1\u20090.12\u00a0\u03bcl\/min HF, 1.49\u2009\u00b1\u20090.15\u00a0\u03bcl\/min control). Increased CSF secretion was seen in both groups following HC treatment (by 132% in controls and 114% in HF) but only in control rats following TNF-\u03b1 treatment (137% increase). The resistance to CSF drainage was not different between control and HF fed female rats (6.13\u2009\u00b1\u20090.44\u00a0mmH<jats:sub>2<\/jats:sub>O\u00a0min\/\u03bcl controls, and 7.09\u2009\u00b1\u20090.26\u00a0mmH<jats:sub>2<\/jats:sub>O\u00a0min\/\u03bcl HF). and when treated with CCL2, both groups displayed an increase in resistance to CSF drainage of 141% (controls) and 139% (HF) indicating lower levels of CSF drainage.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Weight loss and therapies targeting HC, TNF-\u03b1 and CCL2, whether separately or in combination, may be beneficial to modulate rates of CSF secretion and\/or resistance to CSF drainage pathways, both factors likely contributing to the raised intracranial pressure (ICP) observed in female IIH patients with obesity.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12987-020-0168-z","type":"journal-article","created":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T00:02:28Z","timestamp":1581292948000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Cerebrospinal fluid dynamics modulation by diet and cytokines in rats"],"prefix":"10.1186","volume":"17","author":[{"given":"Zerin","family":"Alimajstorovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Pascual-Baixauli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl A.","family":"Hawkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basil","family":"Sharrack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Jane","family":"Loughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio A.","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8018-9637","authenticated-orcid":false,"given":"Jane E.","family":"Preston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,10]]},"reference":[{"issue":"2","key":"168_CR1","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/j.1526-4610.2008.001329.x","volume":"49","author":"S Dhungana","year":"2009","unstructured":"Dhungana S, Sharrack B, Woodroofe N. Cytokines and chemokines in idiopathic intracranial hypertension. Headache. 2009;49(2):282\u20135.","journal-title":"Headache"},{"issue":"6","key":"168_CR2","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1136\/practneurol-2018-002009","volume":"18","author":"SP Mollan","year":"2018","unstructured":"Mollan SP, et al. Evaluation and management of adult idiopathic intracranial hypertension. Pract Neurol. 2018;18(6):485.","journal-title":"Pract Neurol"},{"issue":"8","key":"168_CR3","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1001\/archneur.1982.00510200003001","volume":"39","author":"JJ Corbett","year":"1982","unstructured":"Corbett JJ, et al. Visual loss in pseudotumor cerebri: follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual loss. Arch Neurol. 1982;39(8):461\u201374.","journal-title":"Arch Neurol"},{"issue":"2","key":"168_CR4","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00701-018-3772-9","volume":"161","author":"M Ardissino","year":"2019","unstructured":"Ardissino M, et al. Idiopathic intracranial hypertension in the British population with obesity. Acta Neurochir. 2019;161(2):239\u201346.","journal-title":"Acta Neurochir"},{"issue":"10","key":"168_CR5","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1111\/ene.13739","volume":"25","author":"G McCluskey","year":"2018","unstructured":"McCluskey G, et al. Meta-analysis and systematic review of population-based epidemiological studies in idiopathic intracranial hypertension. Eur J Neurol. 2018;25(10):1218\u201327.","journal-title":"Eur J Neurol"},{"issue":"4","key":"168_CR6","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.neuroscience.2004.07.003","volume":"129","author":"PD Brown","year":"2004","unstructured":"Brown PD, et al. Molecular mechanisms of cerebrospinal fluid production. Neuroscience. 2004;129(4):957\u201370.","journal-title":"Neuroscience"},{"issue":"1","key":"168_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12987-016-0040-3","volume":"13","author":"SB Hladky","year":"2016","unstructured":"Hladky SB, Barrand MA. Fluid and ion transfer across the blood-brain and blood-cerebrospinal fluid barriers; a comparative account of mechanisms and roles. Fluids Barriers CNS. 2016;13(1):19.","journal-title":"Fluids Barriers CNS"},{"issue":"35","key":"168_CR8","doi-asserted-by":"publisher","first-page":"5463","DOI":"10.2174\/1381612822666160726112115","volume":"22","author":"N Strazielle","year":"2016","unstructured":"Strazielle N, Ghersi-Egea JF. Potential pathways for CNS drug delivery across the blood\u2013cerebrospinal fluid barrier. Curr Pharm Des. 2016;22(35):5463\u201376.","journal-title":"Curr Pharm Des"},{"issue":"2","key":"168_CR9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10014-016-0255-7","volume":"33","author":"M Ueno","year":"2016","unstructured":"Ueno M, et al. Blood\u2013brain barrier and blood\u2013cerebrospinal fluid barrier in normal and pathological conditions. Brain Tumor Pathol. 2016;33(2):89\u201396.","journal-title":"Brain Tumor Pathol"},{"key":"168_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1743-8454-5-10","volume":"5","author":"CE Johanson","year":"2008","unstructured":"Johanson CE, et al. Multiplicity of cerebrospinal fluid functions: new challenges in health and disease. Cerebrospinal Fluid Res. 2008;5:10.","journal-title":"Cerebrospinal Fluid Res"},{"issue":"7","key":"168_CR11","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1084\/jem.20142290","volume":"212","author":"A Aspelund","year":"2015","unstructured":"Aspelund A, et al. A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J Exp Med. 2015;212(7):991\u20139.","journal-title":"J Exp Med"},{"issue":"1","key":"168_CR12","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1038\/s41467-018-04677-9","volume":"9","author":"AB Steffensen","year":"2018","unstructured":"Steffensen AB, et al. Cotransporter-mediated water transport underlying cerebrospinal fluid formation. Nat Commun. 2018;9(1):2167.","journal-title":"Nat Commun"},{"issue":"1","key":"168_CR13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/1097-0029(20010101)52:1<137::AID-JEMT15>3.0.CO;2-J","volume":"52","author":"M Haselbach","year":"2001","unstructured":"Haselbach M, et al. Porcine choroid plexus epithelial cells in culture: regulation of barrier properties and transport processes. Microsc Res Tech. 2001;52(1):137\u201352.","journal-title":"Microsc Res Tech"},{"issue":"6","key":"168_CR14","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1210\/en.2003-0285","volume":"144","author":"CJ Lyon","year":"2003","unstructured":"Lyon CJ, Law RE, Hsueh WA. Minireview: adiposity, inflammation, and atherogenesis. Endocrinology. 2003;144(6):2195\u2013200.","journal-title":"Endocrinology"},{"issue":"2","key":"168_CR15","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1378\/chest.118.2.503","volume":"118","author":"CA Dinarello","year":"2000","unstructured":"Dinarello CA. Proinflammatory cytokines. Chest. 2000;118(2):503\u20138.","journal-title":"Chest"},{"issue":"2","key":"168_CR16","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/01.shk.0000131193.80038.f1","volume":"22","author":"T Hayakata","year":"2004","unstructured":"Hayakata T, et al. Changes in CSF S100B and cytokine concentrations in early-phase severe traumatic brain injury. Shock. 2004;22(2):102\u20137.","journal-title":"Shock"},{"issue":"3","key":"168_CR17","first-page":"234","volume":"2","author":"LJ Edwards","year":"2013","unstructured":"Edwards LJ, et al. Increased levels of interleukins 2 and 17 in the cerebrospinal fluid of patients with idiopathic intracranial hypertension. Am J Clin Exp Immunol. 2013;2(3):234\u201344.","journal-title":"Am J Clin Exp Immunol"},{"issue":"2","key":"168_CR18","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3923\/jms.2008.205.208","volume":"8","author":"H Reihani-Kermani","year":"2008","unstructured":"Reihani-Kermani H, et al. Cerebrospinal fluid concentration of interleukin-6 and interleukin-10 in idiopathic intracranial hypertension. J Med Sci. 2008;8(2):205\u20138.","journal-title":"J Med Sci"},{"issue":"12","key":"168_CR19","doi-asserted-by":"publisher","first-page":"5348","DOI":"10.1210\/jc.2010-0729","volume":"95","author":"AJ Sinclair","year":"2010","unstructured":"Sinclair AJ, et al. Cerebrospinal fluid corticosteroid levels and cortisol metabolism in patients with idiopathic intracranial hypertension: a link between 11beta-HSD1 and intracranial pressure regulation? J Clin Endocrinol Metab. 2010;95(12):5348\u201356.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"168_CR20","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1093\/brain\/93.4.679","volume":"93","author":"AV Lorenzo","year":"1970","unstructured":"Lorenzo AV, Page LK, Watters GV. Relationship between cerebrospinal fluid formation, absorption and pressure in human hydrocephalus. Brain. 1970;93(4):679\u201392.","journal-title":"Brain"},{"issue":"1","key":"168_CR21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/0165-3806(87)90172-6","volume":"430","author":"HC Jones","year":"1987","unstructured":"Jones HC, Deane R, Bucknall RM. Developmental changes in cerebrospinal fluid pressure and resistance to absorption in rats. Brain Res. 1987;430(1):23\u201330.","journal-title":"Brain Res"},{"issue":"11","key":"168_CR22","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1001\/archopht.117.11.1571","volume":"117","author":"FJ Rowe","year":"1999","unstructured":"Rowe FJ, Sarkies NJ. Visual outcome in a prospective study of idiopathic intracranial hypertension. Arch Ophthalmol. 1999;117(11):1571.","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"168_CR23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/0022-510X(93)90084-C","volume":"116","author":"K Radhakrishnan","year":"1993","unstructured":"Radhakrishnan K, et al. Epidemiology of idiopathic intracranial hypertension: a prospective and case-control study. J Neurol Sci. 1993;116(1):18\u201328.","journal-title":"J Neurol Sci"},{"key":"168_CR24","doi-asserted-by":"publisher","first-page":"R1787","DOI":"10.1152\/ajpregu.00063.2005","volume":"289","author":"MS Amin","year":"2005","unstructured":"Amin MS, et al. Distribution of epithelial sodium channels and mineralocorticoid receptors in cardiovascular regulatory centers in rat brain. Am J Physiol Regul Integr Comp Physiol. 2005;289:R1787\u201397.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"5","key":"168_CR25","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1210\/er.2003-0031","volume":"25","author":"JW Tomlinson","year":"2004","unstructured":"Tomlinson JW, et al. 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Rev. 2004;25(5):831\u201366.","journal-title":"Endocr Rev"},{"issue":"8","key":"168_CR26","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1001\/archneur.1988.00520320065016","volume":"45","author":"FJ Durcan","year":"1988","unstructured":"Durcan FJ, Corbett JJ, Wall M. The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Arch Neurol. 1988;45(8):875\u20137.","journal-title":"Arch Neurol"},{"issue":"9","key":"168_CR27","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1212\/01.WNL.0000066683.34093.E2","volume":"60","author":"RI Farb","year":"2003","unstructured":"Farb RI, et al. Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis. Neurology. 2003;60(9):1418\u201324.","journal-title":"Neurology"},{"issue":"4","key":"168_CR28","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1136\/jnnp.2003.021006","volume":"75","author":"JN Higgins","year":"2004","unstructured":"Higgins JN, et al. MR venography in idiopathic intracranial hypertension: unappreciated and misunderstood. J Neurol Neurosurg Psychiatry. 2004;75(4):621\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"168_CR29","first-page":"42","volume":"7","author":"R Bagga","year":"2005","unstructured":"Bagga R, et al. Choice of therapy and mode of delivery in idiopathic intracranial hypertension during pregnancy. MedGenMed. 2005;7(4):42.","journal-title":"MedGenMed"},{"issue":"6","key":"168_CR30","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1006\/cyto.1996.0186","volume":"9","author":"XH Zhu","year":"1997","unstructured":"Zhu XH, et al. Effects of prolactin and metoclopramide on macrophage cytokine gene expression in late sepsis. Cytokine. 1997;9(6):437\u201346.","journal-title":"Cytokine"},{"issue":"4","key":"168_CR31","first-page":"313","volume":"1","author":"EA Young","year":"1996","unstructured":"Young EA. Sex differences in response to exogenous corticosterone: a rat model of hypercortisolemia. Mol Psychiatry. 1996;1(4):313\u20139.","journal-title":"Mol Psychiatry"},{"issue":"3","key":"168_CR32","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1055\/s-2007-979001","volume":"29","author":"A Pfeiffer","year":"1997","unstructured":"Pfeiffer A, et al. Circulating tumor necrosis factor alpha is elevated in male but not in female patients with type II diabetes mellitus. Horm Metab Res. 1997;29(3):111\u20134.","journal-title":"Horm Metab Res"},{"issue":"6","key":"168_CR33","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1074\/jbc.270.6.2427","volume":"270","author":"G Fisone","year":"1995","unstructured":"Fisone G, et al. Na+, K(+)-ATPase in the choroid plexus. Regulation by serotonin\/protein kinase C pathway. J Biol Chem. 1995;270(6):2427\u201330.","journal-title":"J Biol Chem"},{"issue":"20","key":"168_CR34","doi-asserted-by":"publisher","first-page":"14923","DOI":"10.1074\/jbc.M701411200","volume":"282","author":"JG Kim","year":"2007","unstructured":"Kim JG, et al. Thyroid transcription factor-1 facilitates cerebrospinal fluid formation by regulating aquaporin-1 synthesis in the brain. J Biol Chem. 2007;282(20):14923\u201331.","journal-title":"J Biol Chem"},{"issue":"2","key":"168_CR35","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1177\/0333102418776455","volume":"39","author":"WJ Scotton","year":"2019","unstructured":"Scotton WJ, et al. Topiramate is more effective than acetazolamide at lowering intracranial pressure. Cephalalgia. 2019;39(2):209\u201318.","journal-title":"Cephalalgia"},{"issue":"1","key":"168_CR36","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S1474-4422(15)00298-7","volume":"15","author":"KA Markey","year":"2016","unstructured":"Markey KA, et al. Understanding idiopathic intracranial hypertension: mechanisms, management, and future directions. Lancet Neurol. 2016;15(1):78\u201391.","journal-title":"Lancet Neurol"},{"issue":"2","key":"168_CR37","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.lab.2004.09.011","volume":"145","author":"CJ Glueck","year":"2005","unstructured":"Glueck CJ, et al. Idiopathic intracranial hypertension, polycystic-ovary syndrome, and thrombophilia. J Lab Clin Med. 2005;145(2):72\u201382.","journal-title":"J Lab Clin Med"},{"key":"168_CR38","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.125348","author":"MW O\u2019Reilly","year":"2019","unstructured":"O\u2019Reilly MW, et al. A unique androgen excess signature in idiopathic intracranial hypertension is linked to cerebrospinal fluid dynamics. JCI Insight. 2019. https:\/\/doi.org\/10.1172\/jci.insight.125348.","journal-title":"JCI Insight"},{"issue":"3","key":"168_CR39","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1210\/jc.2013-3399","volume":"99","author":"MW O\u2019Reilly","year":"2014","unstructured":"O\u2019Reilly MW, et al. Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione. J Clin Endocrinol Metab. 2014;99(3):1027\u201336.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"168_CR40","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1038\/sj.jcbfm.9600306","volume":"26","author":"O Bloch","year":"2006","unstructured":"Bloch O, et al. Accelerated progression of kaolin-induced hydrocephalus in aquaporin-4-deficient mice. J Cereb Blood Flow Metab. 2006;26(12):1527\u201337.","journal-title":"J Cereb Blood Flow Metab"},{"key":"168_CR41","volume":"2012","author":"S Li","year":"2012","unstructured":"Li S, et al. IL-17 and IL-22 in cerebrospinal fluid and plasma are elevated in Guillain\u2013Barre syndrome. Mediat Inflamm. 2012;260473.","journal-title":"Mediat Inflamm"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-020-0168-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12987-020-0168-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-020-0168-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T01:44:11Z","timestamp":1612835051000},"score":1,"resource":{"primary":{"URL":"https:\/\/fluidsbarrierscns.biomedcentral.com\/articles\/10.1186\/s12987-020-0168-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,10]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["168"],"URL":"https:\/\/doi.org\/10.1186\/s12987-020-0168-z","relation":{},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,10]]},"assertion":[{"value":"17 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Animal procedures were carried out under the Animals (Scientific Procedures Act UK 1986 revised) Home Office Project licence PPL 70\/8507.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}